Health

Pharmanovia, a pharmaceutical firm that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, announced the expansion of its neurology portfolio with the acquisition of 11 central nervous system (CNS) brands from healthcare company, Sanofi. The brands span four therapy areas of ongoing unmet need associated with CNS disorders - psycholeptic, anxiolytic, anti-epileptic and anti-psychotic.

Organon, a healthcare company with a focus on women’s health, has appointed Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owens, M.D., as Head of Medical Affairs and Outcomes Research, strengthening its medical capabilities, advancing external relationships and fueling efforts to bring forward innovations to solve unmet health needs. They both report to Sandra Milligan, M.D., J.D., Head of Research and Development.

Former professional cricketer Ryan Carters, used this Father’s Day to launch a new support organisation for the dads of Australia and is calling for an urgent boost in Federal Government funding to help support struggling fathers who are battling increased mental health issues. Carters, a father of three, who played for the Sydney Sixers, the Cricket Australia XI, New South Wales and Victoria, said not enough was being done by all levels of Australia's Government to help address systemic issues facing dads and said there needed to be a holistic level of coordinated support networks and programs for fathers. After six months of highly successful community trials, Carters has officially launched the Dadfit program.

Australia is infamous for having the highest skin cancer rates, a gloomy accolade that doesn’t seem to be fading anytime soon. But beneath this widespread knowledge lies a less publicised yet deeply concerning issue: the frequency with which skin cancers are misdiagnosed. When Aussies suspect they might have a skin cancer, the default method by a GP to confirm this is an invasive biopsy, a procedure only registered doctors can perform. But due to the fact that most GPs aren't specialists in the area, many skin cancers are incorrectly diagnosed.

CAS, a division of the American Chemical Society specializing in scientific information solutions, and Molecule.one, a tech-bio specialist in AI-based solutions for pharmaceutical chemistry, have established a strategic collaboration focused on the joint development of computer-aided synthesis design technologies to help accelerate scientific breakthroughs in early-stage drug discovery and aid chemists in the discovery of novel small molecules.

The Royal Flying Doctor Service (RFDS), Australia’s rural and remote health services provider, launched a new nationwide Electronic Health Record (EHR) powered by Oracle Autonomous Database, running on Oracle Cloud Infrastructure (OCI), to streamline clinical information collection and analysis leading to faster and better decision-making by medical staff.

Medisca has announced the expansion of a network of strategic alliances aimed at securing and stabilizing global access to high quality active pharmaceutical ingredients (APIs) for the preparation of essential medications. This mission started with the partnership for Thyroid USP in 2021, and has now expanded to include Progesterone USP (Special Micronized), Testosterone USP (Micronized), Diclofenac Sodium USP, and Ketamine Hydrochloride USP.

Cancer-related fatigue (CRF), a debilitating condition impacting up to 60% of cancer patients, can be significantly alleviated using supervised exercise programs, according to research published in the Royal Australasian College of Physicians’ (RACP) Internal Medicine Journal. Australia ranks third in the world for incidence of cancer. One in two Australians will develop at least one type of cancer before the age of 85. Due to world-class care, Australians have some of the highest cancer-related survival rates internationally. However, while our health system is saving people’s lives, it is not necessarily helping them thrive post-treatment.

Biocytogen Pharmaceuticals Co., Ltd. announced that its Project Integrum has completed 2 core milestones, and its antibody business is now entering a new stage of rapid growth. Project Integrum is a large-scale research and development (R&D) project that is designed to discover novel therapeutic antibodies for over 1000 druggable targets.

RoslinCT, a contract development and manufacturing organization (CDMO) for Advanced Cell and Gene therapies, has appointed Derek Hei, Ph.D., to its Scientific Advisory Board (SAB). The SAB is comprised of cell and gene therapy pioneers with experience, providing valuable insight into various topics for the development and manufacturing of advanced therapies.